Rosenberg, Steven A.

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.

Barth, R. J., Mulé, J. J., Spiess, P. J., & Rosenberg, S. A. (1991) · The Journal of experimental medicine

Immunotherapy and Immune ResponsesT-cell and B-cell Immunology

Cited by 402

Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4

Program, N. C. S., Prickett, T. D., Agrawal, N. S., Wei, X., Yates, K. E., Lin, J. C., Wunderlich, J. R., Cronin, J. C., Cruz, P., Rosenberg, S. A., et al. (2009) · Nature Genetics

Melanoma and MAPK PathwaysCancer Genomics and Diagnostics

Cited by 352

High-Efficiency Transfection of Primary Human and Mouse T Lymphocytes Using RNA Electroporation

Zhao, Y., Zheng, Z., Cohen, C. J., Gattinoni, L., Palmer, D. C., Restifo, N. P., Rosenberg, S. A., & Morgan, R. A. (2006) · Molecular Therapy

Microbial Inactivation MethodsRNA Interference and Gene Delivery

Cited by 283

A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers

Hanada, K.-I., Zhao, C., Gil-Hoyos, R., Gartner, J. J., Chow-Parmer, C., Lowery, F. J., Krishna, S., Prickett, T. D., Kivitz, S., Parkhurst, M. R., et al. (2022) · Cancer Cell

Cancer Immunotherapy and BiomarkersCAR-T cell therapy research

Cited by 200

Phenotype and Function of T Cells Infiltrating Visceral Metastases from Gastrointestinal Cancers and Melanoma: Implications for Adoptive Cell Transfer Therapy

Turcotte, S., Gros, A., Hogan, K., Tran, E., Hinrichs, C. S., Wunderlich, J. R., Dudley, M. E., & Rosenberg, S. A. (2013) · The Journal of Immunology

Immunotherapy and Immune ResponsesCAR-T cell therapy research

Cited by 107

Recurrent inactivating RASA2 mutations in melanoma

Arafeh, R., Qutob, N., Emmanuel, R., Keren-Paz, A., Madore, J., Elkahloun, A., Wilmott, J. S., Gartner, J. J., Di Pizio, A., Winograd-Katz, S., et al. (2015) · Nature Genetics

Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling

Cited by 107

Large scale production of human lymphokine activated killer cells for use in adoptive immunotherapy

Mesler Muul, L., Director, E. P., Hyatt, C. L., & Rosenberg, S. A. (1986) · Journal of Immunological Methods

Immune Cell Function and InteractionImmunotherapy and Immune Responses

Cited by 82

Immunotherapy for metastatic solid cancers

Turcotte, S., & Rosenberg, S. A. (2011) · Advances in Surgery

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 81

Penetration of recombinant interleukin-2 across the blood-cerebrospinal fluid barrier

Saris, S. C., Rosenberg, S. A., Friedman, R. B., Rubin, J. T., Barba, D., & Oldfield, E. H. (1988) · Journal of Neurosurgery

Barrier Structure and Function StudiesCerebrospinal fluid and hydrocephalus

Cited by 79

Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients

Casati, A., Varghaei-Nahvi, A., Feldman, S. A., Assenmacher, M., Rosenberg, S. A., Dudley, M. E., & Scheffold, A. (2013) · Cancer Immunology, Immunotherapy

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 73

Replication-Competent Retroviruses in Gene-Modified T Cells Used in Clinical Trials: Is It Time to Revise the Testing Requirements?

Bear, A. S., Morgan, R. A., Cornetta, K., June, C. H., Binder-Scholl, G., Dudley, M. E., Feldman, S. A., Rosenberg, S. A., Shurtleff, S. A., Rooney, C. M., et al. (2012) · Molecular Therapy

Virus-based gene therapy researchCAR-T cell therapy research

Cited by 59

Anti-CD19 CAR T Cells Administered after Low-Dose Chemotherapy Can Induce Remissions of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma

Kochenderfer, J. N., Somerville, R., Lu, L., Iwamoto, A., Yang, J. C., Klebanoff, C., Kammula, U., Sherry, R. M., Victoria, S., Yuan, C., et al. (2014) · Blood

CAR-T cell therapy researchLymphoma Diagnosis and Treatment

Cited by 33

Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain

Mikkilineni, L., Natrakul, D. A., Lam, N., Manasanch, E. E., Mann, J., Weissler, K. A., Wong, N., Brudno, J. N., Goff, S. L., Yang, J. C., et al. (2024) · Molecular Therapy

CAR-T cell therapy researchMultiple Myeloma Research and Treatments

Cited by 16

Treatment of Patients with T Cells Expressing a Fully-Human Anti-BCMA CAR with a Heavy-Chain Antigen-Recognition Domain Caused High Rates of Sustained Complete Responses and Relatively Mild Toxicity

Mikkilineni, L., Manasanch, E. E., Natrakul, D., Brudno, J. N., Mann, J., Goff, S. L., Yang, J. C., Lam, N., Maric, I., Stetler-Stevenson, M., et al. (2021) · Blood

CAR-T cell therapy researchMultiple Myeloma Research and Treatments

Cited by 9